This book provides a comprehensive introduction to collagen and structural proteins. Summarizes data on key structural proteins (collagens, laminins and elastin), reviews how these molecules affect pathologies, and describes how the application and modification of these proteins can be exploited to modulate fibrotic disease.
Chapter 1. Type I Collagen
Chapter 2. Type II Collagen
Chapter 3. Type III Collagen
Chapter 4. Type IV Collagen
Chapter 5. Type V Collagen
Chapter 6. Type VI Collagen
Chapter 7. Type VII Collagen
Chapter 8. Type VIII Collagen
Chapter 9. Type IX Collagen
Chapter 10. Type X Collagen
Chapter 11. Type XI Collagen
Chapter 12. Type XII Collagen
Chapter 13. Type XIII Collagen
Chapter 14. Type XIV Collagen
Chapter 15. Type XV Collagen
Chapter 16. Type XVI Collagen
Chapter 17. Type XVII Collagen
Chapter 18. Type XVIII Collagen
Chapter 19. Type XIX Collagen
Chapter 20. Type XX Collagen
Chapter 21. Type XXI Collagen
Chapter 22. Type XXII Collagen
Chapter 23. Type XXIII Collagen
Chapter 24. Type XXIV Collagen
Chapter 25. Type XXV Collagen
Chapter 26. Type XXVI Collagen
Chapter 27. Type XXVII Collagen
Chapter 28. Type XXVIII Collagen
Chapter 29. Laminins
Chapter 30. Elastin
Chapter 31. Structural Biomarkers
Morten Karsdal has been CEO of Nordic Bioscience A/S since June 2010. Since 2002, Morten Karsdal has focused his research on the discovery and development of novel biochemical markers. This has resulted in the development of more than 15 ELISA assays for detecting biomarkers that have been used for research in the fields of fibrosis, osteoporosis and osteoarthritis. One of these assays has been 510(k) approved by the Food and Drug Administration (FDA) in the USA.
 |
Ask a Question About this Product More... |
|
